Testing drug additivity based on monotherapies. - Wikidata - awgldk - TriplyDB

Testing drug additivity based on monotherapies.

Testing drug additivity based on monotherapies.

http://www.wikidata.org/entity/Q40951880

about

Drug delivery of oral anti-cancer fluoropyrimidine agents.

P2860

Q48317852-0FE50141-9792-4930-8D10-053591416070

P2860

Testing drug additivity based on monotherapies.

http://www.wikidata.org/entity/Q40951880

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Testing drug additivity based on monotherapies.

@en

type

label

Testing drug additivity based on monotherapies.

@en

prefLabel

Testing drug additivity based on monotherapies.

@en

P1433

Q40951880-301CE2A9-2CF7-48FD-9A62-4BCC1979B5BC

P1476

Q40951880-794DB7E3-A8E6-44FF-BEAB-09AB630E1FCE

P2093

Q40951880-23415AF7-2802-4F1F-BD23-73B928F30932

Q40951880-839C9757-8785-4B85-9270-7E106ADCC0D3

Q40951880-A5A64E2F-2AD0-4BD3-84D5-3BFCA1C162B5

P2860

Q40951880-31DE7FED-0C88-44F5-830E-1501F10BCD39

Q40951880-3CDDBD43-6E4D-466C-94E5-581CDF17AF1A

Q40951880-43361E25-47B1-4E40-905B-2AF8F0A334EB

Q40951880-4E77F329-F050-4AFE-824F-05D0FF5B1CCF

Q40951880-7B1D742A-4590-47CC-A22F-B5CD538A1139

Q40951880-A776DBC1-5124-4A09-9C19-96972A0DF75D

Q40951880-E801D5C5-4D9C-49AD-A43F-4E31327A92BF

P304

Q40951880-4484EE93-8DAA-4CCC-AF0E-BE7B481DF89C

P31

Q40951880-BFCBAC4A-A968-4A6D-8A8D-E0E91B99AA9C

P356

Q40951880-85F97880-774D-453D-A7DC-83B3EBF3BAAF

P433

Q40951880-C7F3D6B3-AFED-4A59-9004-FF89475CB3D3

P478

Q40951880-DD0243CD-90E0-45F1-BD04-25A797E1137D

P577

Q40951880-3E416739-1BB8-43FE-8D83-4738535B7F00

P698

Q40951880-FA1AF4FF-0BDB-4E82-9531-06A546625251

P356

P1433

Pharmaceutical Statistics

P1476

Testing drug additivity based on monotherapies.

@en

P2093

Harry Yang

http://www.w3.org/2001/XMLSchema#string

Steven J Novick

http://www.w3.org/2001/XMLSchema#string

Wei Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

Nonlinear blending: a useful general concept for the assessment of combination drug synergy.

A semiparametric response surface model for assessing drug interaction.

A three-dimensional model to analyze drug-drug interactions.

Equivalence testing for parallelism in the four-parameter logistic model.

Comparability of critical quality attributes for establishing biosimilarity.

Assessing nonsuperiority, noninferiority, or equivalence when comparing two regression models over a restricted covariate region.

P304

332-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PST.1689

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25962689

http://www.w3.org/2001/XMLSchema#string